0001578563-25-000197.txt : 20250401 0001578563-25-000197.hdr.sgml : 20250401 20250401160104 ACCESSION NUMBER: 0001578563-25-000197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250328 FILED AS OF DATE: 20250401 DATE AS OF CHANGE: 20250401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEIL GARRY ARTHUR CENTRAL INDEX KEY: 0001586785 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 25799503 MAIL ADDRESS: STREET 1: 555 CALIFORNIA STREET STREET 2: SUITE 365 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2025-03-28 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001586785 NEIL GARRY ARTHUR C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 0 1 0 0 Chief Executive Officer 0 Common Stock 2025-03-28 4 M 0 64867 A 64927 D Common Stock 2025-03-28 4 F 0 17787 8.46 D 47140 D Restricted Stock Units 2025-03-28 4 M 0 64867 0 A Common Stock 64867 129733 D Restricted stock units convert into common stock on a one-for-one basis. On August 13, 2024, the Reporting Person was granted 194,600 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date. /s/ Donald R. Reynolds, by Power of Attorney 2025-04-01